Product Information
PROMETHAZINE 50 MG TABLET is a generic product labeled by KVK-Tech Inc., priced at $0.0820 per EA under NDC 10702000401. Its NADAC has been published 671 times since Nov 28, 2013.
FDA first approved this application on Jul 31, 2006. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
50 mg/1
Manufacturer
KVK-Tech Inc.NDC
10702000401
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
PROMETHAZINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA040712FDA Approved
7/31/2006
TE Code
AB
On Market Since
7/31/2006
Pharmacological Classes
Price Statistics
The NADAC for PROMETHAZINE 50 MG TABLET has been published 671 times since Nov 28, 2013, and over the history we have for it it has declined 58.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0820 per EA |
|---|---|
| All-time high | $0.2152 (Feb 12, 2014) |
| All-time low | $0.0689 (Oct 20, 2021) |
| 52-week high | $0.0880 |
| 52-week low | $0.0772 |
| Median price | $0.1035 |
| Average price | $0.1145 |
| Largest weekly change | +48.5% (Aug 19, 2015) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the promethazine hydrochloride market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
KVK-Tech Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
promethazine hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Phenothiazine class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of PROMETHAZINE 50 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for PROMETHAZINE 50 MG TABLET, manufactured by KVK-Tech Inc., is $0.0820 per EA (NDC 10702000401), effective Sep 30, 2026.
How has the price of PROMETHAZINE 50 MG TABLET changed over time?
Over the history we have for it, the NADAC for PROMETHAZINE 50 MG TABLET has declined 58.8%. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for PROMETHAZINE 50 MG TABLET?
Since Nov 28, 2013, the NADAC for PROMETHAZINE 50 MG TABLET has ranged from a low of $0.0689 (Oct 20, 2021) to a high of $0.2152 (Feb 12, 2014), with a median of $0.1035 per EA.
Are there cheaper alternatives to PROMETHAZINE 50 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of PROMETHAZINE 50 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures PROMETHAZINE 50 MG TABLET?
PROMETHAZINE 50 MG TABLET (NDC 10702000401) is labeled by KVK-Tech Inc., and CMS classifies it as a generic product.